By inhibiting the phosphorylation of MAPK and NF-κB signaling pathways in macrophages, it is possible to effectively suppress the expression of inflammatory factors in LPS-induced macrophages and alleviate ALI [34,44,54,69,120]. The gene discussed is NFKB1; the disease is acute respiratory distress syndrome.